Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Multiple Myeloma: A Textbook for Nurses

TON - February 2011 Vol 4, No 1 published on February 16, 2011 in Hematologic Cancers
Sandra Kurtin, RN, MS, AOCN, ANP-C

Multiple myeloma (MM) is a disease with variable presentation, disease trajectory, prognosis, and options for treatment. Integrating the plethora of scientific discovery relative to plasma cell disorders, molecular and cytogenetic attributes and their implications for prognosis and treatment, identification of key components of the bone marrow micro - environment, and the development of novel therapies targeting many of these attributes requires a thorough review of multiple sources of information. Multiple Myeloma: A Textbook for Nurses, edited by Joseph D. Tariman, is a well-organized, comprehensive, nursing- and patient-focused guide to understanding the complexity of MM and clinically relevant practical tools for management.

Tariman and his colleagues have succeeded in assimilating the key scientific discoveries of the past two decades relative to plasma cell disorders, including MM. The contributing authors represent years of nursing expertise from a variety of practice settings and nursing roles. Nursing’s unique contributions to scientific developments, clinical management, and support of patients and families with MM are celebrated in this book.

The text begins with a historical perspective of the disease, with thoughtful reflections on the challenges faced by patients and care providers. A review of the anatomy and physiology of plasma cells, the immune system, and the pathophysiology associated with MM uses detailed figures and tables to foster integration of complex concepts. Subsequent chapters provide a logically organized tool for nurses, including advanced practitioners in oncology, describing diagnostic evaluation, risk-adapted treatment selection, and strategies for management. Treatment options for the newly diagnosed patient, transplant-eligible or -ineligible patients, salvage therapy, and stemcell transplant are described, with details of recent clinical trials and advances in supportive care. Each chapter includes detailed tables and figures that summarize key points and provide practical tools for day-to-day clinical practice throughout the continuum of care. The final chapters address strategies for patient education, development and support of a survivorship plan, and the importance of continued nursing research.

Each chapter is thoughtfully prepared and provides insight that can be offered only by nursing colleagues who have a passion for their work and continue to strive for excellence in oncology nursing. The book offers something for oncology nursing professionals of all levels of expertise

Related Items
CAR T-Cell Therapy Shows Highly Durable Remissions in CLL and B-Cell Lymphoma
Charlie Dawson
TON - August 2020, Vol 13, No 4 published on August 14, 2020 in Hematologic Cancers
Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular lymphoma and Marginal-Zone lymphoma
William King
TON - August 2020, Vol 13, No 4 published on August 14, 2020 in Hematologic Cancers
November 4, 2019 — Oncology News & Updates
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Palliative Care Use Dismal Among Patients with Hematologic Malignancies
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in Conference Correspondent, ASH, Palliative Care, Hematologic Cancers
Educating Your Patients About Daratumumab
Leslie Lauersdorf, ARNP
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
How to Handle Survivorship Care for Multiple Myeloma
Tiffany Richards, PhD, ANP-BC
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
How to Utilize New Mutliple Myeloma Drugs
Tiffany Richards, PhD, ANP-BC
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Preparing Your Patients for Side Effects
Tiffany Richards, PhD, ANP-BC
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Know Your Patients' Baselines
Tiffany Richards, PhD, ANP-BC
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Meeting the Needs of the Patient
Tiffany Richards, PhD, ANP-BC
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Last modified: April 27, 2020